Julien Meissonnier
Chief Tech/Sci/R&D Officer en CATALENT, INC. .
Perfil
Fundador de Accellix, Inc., Julien Meissonnier ocupa actualmente el cargo de Presidente y Director en Accellix, Inc. y Director Científico y Vicepresidente en Catalent, Inc. (una filial de Catalent, Inc.). Anteriormente ocupó el cargo de Presidente y Director General de Cardio Ventures Ltd., Director de Desarrollo Comercial en Sol-Gel Technologies Ltd., Director de Marketing y Desarrollo Comercial en Evogene Ltd., Director de Marketing Global en Novartis AG y Director de Marketing Global en Ciba-Geigy AG (una filial de Novartis AG) e Ingeniero de Desarrollo en Rhone-Poulenc SA. Se licenció en la Universidad de Washington y obtuvo un MBA en el INSEAD.
Cargos activos de Julien Meissonnier
Empresas | Cargo | Inicio |
---|---|---|
CATALENT, INC. | Chief Tech/Sci/R&D Officer | 19/11/2019 |
Accellix, Inc.
Accellix, Inc. Medical SpecialtiesHealth Technology Accellix, Inc. develops in-vitro diagnostic systems. Its Accellix platform is an affordable tabletop diagnostic device with single-use assay cartridges that does not require extensive training nor involve complex operational processes. The firm’s product is an application for the rapid identification of sepsis, a condition associated with high morbidity and mortality with no existing rapid diagnostic test. The company was founded in 2009 by Julien Meissonnier and Harvey Kasdan and is headquartered in San Jose, CA. | Founder | 01/01/2009 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Chief Tech/Sci/R&D Officer | 01/10/2019 |
Antiguos cargos conocidos de Julien Meissonnier.
Empresas | Cargo | Fin |
---|---|---|
Cardio Ventures Ltd.
Cardio Ventures Ltd. Investment ManagersFinance Cardio Ventures Ltd is a venture capital firm. The firm headquartered in Jerusalem, Israel. | Chief Executive Officer | 01/01/2011 |
SOL-GEL TECHNOLOGIES LTD. | Corporate Officer/Principal | - |
NOVARTIS AG | Sales & Marketing | - |
Ciba-Geigy AG
Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland. | Sales & Marketing | - |
EVOGENE LTD. | Sales & Marketing | - |
Formación de Julien Meissonnier.
University of Washington | Graduate Degree |
INSEAD | Masters Business Admin |
École Nationale Supérieure d'Ingénieurs de Caen | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 4 |
---|---|
NOVARTIS AG | Health Technology |
SOL-GEL TECHNOLOGIES LTD. | Health Technology |
EVOGENE LTD. | Health Technology |
CATALENT, INC. | Health Technology |
Empresas privadas | 5 |
---|---|
Accellix, Inc.
Accellix, Inc. Medical SpecialtiesHealth Technology Accellix, Inc. develops in-vitro diagnostic systems. Its Accellix platform is an affordable tabletop diagnostic device with single-use assay cartridges that does not require extensive training nor involve complex operational processes. The firm’s product is an application for the rapid identification of sepsis, a condition associated with high morbidity and mortality with no existing rapid diagnostic test. The company was founded in 2009 by Julien Meissonnier and Harvey Kasdan and is headquartered in San Jose, CA. | Health Technology |
Ciba-Geigy AG
Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland. | Health Technology |
Rhone-Poulenc SA | Process Industries |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Health Technology |
Cardio Ventures Ltd.
Cardio Ventures Ltd. Investment ManagersFinance Cardio Ventures Ltd is a venture capital firm. The firm headquartered in Jerusalem, Israel. | Finance |